KITS Eyecare Reports Record Third Quarter 2025 Results

Executive Summary

• KITS Eyecare reported record Q3 2025 revenue of $52.4 M, up 25.1% YoY, and Adjusted EBITDA of $2.9 M (5.5% margin), a 79% increase.
• Net income surged 1,367% to $1.9 M ($0.06 EPS). Two‑year active customers exceeded 1 million, up 15.7% YoY.
• Management projects Q4 2025 revenue of $52–$54 M and Adjusted EBITDA margin of 4%–6%, and will appoint a Chief Marketing Officer in Q1 2026.

Key Details

• Revenue: $52,392 K (Q3 2025) vs. $41,871 K (Q3 2024); +25.1%.
• Gross Profit: $18,100 K vs. $13,800 K; +31.6%; gross margin 34.6% vs. 32.9%.
• Adjusted EBITDA: $2,862 K vs. $1,599 K; +79%; margin 5.5% vs. 3.8%.
• Net Income: $1,937 K vs. $132 K; +1,367%; EPS (basic) $0.06 vs. $0.00.
• Cash & Cash Equivalents: $19.7 M as of Sep 30 2025 (up from $19.3 M Dec 31 2024).
• Year‑to‑Date (9 months): Revenue $148.6 M (+29.7% YoY); Gross profit $53.3 M (+42.5%); Adjusted EBITDA $8.9 M (+152.5%).
• Active Customers: >1 million (up 15.7% YoY). New customers added in Q3: 305,000 (+36.5% YoY).
• Outlook Q4 2025: Revenue expected $52–$54 M; Adjusted EBITDA margin 4%–6%.
• Upcoming Executive Hire: Chief Marketing Officer to be announced in Q1 2026.
• Conference Call: Thursday, Nov 6 2025 at 5:00 p.m. ET (details provided).

Notable Quotes

“Q3 was another record quarter of profitable growth for KITS,” said Roger Hardy, Co‑Founder and CEO. “We’re adding new customers at a record pace… our momentum continues to build.”